Loading…
Outlook Therapeutics, Inc. is projected to rise to $0.9731 by 2027, a +66% move from its current price of $0.5855. OTLK is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $0.5275 | $0.5859 | $0.6508 | +0.07% |
| May 30 | $0.5055 | $0.5863 | $0.6801 | +0.14% |
| May 31 | $0.4892 | $0.5867 | $0.7037 | +0.21% |
| Jun 1 | $0.476 | $0.5872 | $0.7243 | +0.28% |
| Jun 2 | $0.4647 | $0.5876 | $0.743 | +0.36% |
| Jun 3 | $0.4547 | $0.588 | $0.7604 | +0.43% |
| Jun 4 | $0.4458 | $0.5884 | $0.7767 | +0.50% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4458 | $0.5884 | $0.7767 | +0.50% |
| Week 2 | $0.3993 | $0.5914 | $0.8758 | +1.00% |
| Week 3 | $0.3674 | $0.5943 | $0.9613 | +1.50% |
| Week 4 | $0.3428 | $0.5973 | $1.04 | +2.01% |
| Week 5 | $0.3226 | $0.6002 | $1.12 | +2.52% |
| Week 6 | $0.3056 | $0.6032 | $1.19 | +3.03% |
| Week 7 | $0.2908 | $0.6062 | $1.26 | +3.54% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Outlook Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases.
Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therapeutics, Inc. was formerly known as Oncobiologics, Inc. and changed its name to Outlook Therapeutics, Inc.
in November 2018. Outlook Therapeutics, Inc. was incorporated in 2010 and is based in Iselin, New Jersey.
OTLK is a stock trading with current price $0.5855 and a market capitalization of $70.77M, ranked 4383. The near-term outlook is neutral in 2026, with an average price of $0.5855. The multi-year forecast projects a bullish trajectory thereafter, with the average price rising through 2027 ($0.9731), 2030 ($1.11), 2040 ($2.71), and reaching an average around $5.90 by 2050.
Max forecast values also rise, signaling meaningful upside potential (e.g., $13.56 max in 2050) alongside progressively higher ROIs from 66.2% in 2027 to 907.2% in 2050.
A major floor 84.2% below — a decisive break under it would weaken the trend.
The nearest floor, 63.1% below — buyers have tended to step in here.
Price is pressing into resistance (0.1% away) — a breakout level to watch.
A major ceiling 42.2% above — clearing it would confirm fresh momentum.
Key OTLK support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OTLK market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.3804 | Buy | $0.4113 | Buy |
| MA 10 | $0.305 | Buy | $0.3455 | Buy |
| MA 20 | $0.2742 | Buy | $0.3047 | Buy |
| MA 50 | $0.2704 | Buy | $0.3264 | Buy |
| MA 100 | $0.3689 | Buy | $0.5083 | Buy |
| MA 200 | $0.9682 | Sell | $0.9711 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 81.05 | Sell |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 390.50 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.03 | Buy |
| ROC (12) | 165.16 | Buy |
| Bollinger %B (20,2) | 1.43 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | 0.09 | Buy |
| Awesome (5,34) | 0.10 | Buy |
| Ultimate (7,14,28) | 88.55 | Sell |
| Momentum (10) | 0.34 | Buy |
| Aroon Osc (25) | 52.00 | Buy |
| Hull MA (9) | 0.46 | Buy |
| ADX (14) | 21.32 | Buy |
| ATR (14) | 0.04 | Info |
The 30-day technical picture is bullish, reflected in a bullish sentiment and an RSI14 of 80. The stock’s near-term metrics show a SMA50 of $0.2704 and a SMA200 of $0.9682. Key support is listed at $0.216 and resistance at $0.586. Over the last 30 days, the price has traded between $0.2931 and $1.17, indicating a wide trading range and volatility.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.198 | $0.5855 | $0.8983 | 0% | Neutral | |
| $0.7003 | $0.9731 | $1.46 | +66% | Bullish | |
| $0.6846 | $1.01 | $1.61 | +72% | Bullish | |
| $0.7453 | $1.16 | $1.94 | +98% | Bullish | |
| $0.6802 | $1.11 | $1.93 | +89% | Bullish | |
| $0.5864 | $0.9965 | $1.80 | +70% | Bullish | |
| $0.7316 | $1.30 | $2.41 | +121% | Bullish | |
| $0.7886 | $1.46 | $2.78 | +149% | Bullish | |
| $0.9378 | $1.80 | $3.52 | +207% | Bullish | |
| $1.12 | $2.24 | $4.49 | +283% | Bullish | |
| $1.22 | $2.71 | $5.96 | +363% | Bullish | |
| $2.65 | $5.90 | $13.56 | +907% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $0.198 | $0.5855 | $0.7063 | +0.00% |
| June 2026 | $0.5312 | $0.637 | $0.7916 | +8.80% |
| July 2026 | $0.5122 | $0.6247 | $0.7962 | -1.94% |
| August 2026 | $0.5233 | $0.6467 | $0.8403 | +3.53% |
| September 2026 | $0.5504 | $0.6879 | $0.9077 | +6.36% |
| October 2026 | $0.5246 | $0.6624 | $0.8864 | -3.70% |
| November 2026 | $0.49 | $0.6243 | $0.8456 | -5.75% |
| December 2026 | $0.5101 | $0.6556 | $0.8983 | +5.02% |
Click any year to see its month-by-month OTLK forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
By 2026, OTLK could reach as high as $0.8983, with a base case around $0.5855 and support toward $0.198 — roughly 0% from $0.5855. A consolidation phase looks the most probable path here.
Expect OTLK to range from $0.7003 to $1.46 through 2027. The $0.9731 average target implies a +66% move from current prices. That is up +66% on the projected 2026 average. Momentum favours further upside here.
The OTLK price prediction for 2028 points to an average of $1.01 (low $0.6846, high $1.61) — a potential gain of +72% on today's $0.5855. Buyers look set to stay in control over this stretch.
In 2029, OTLK is projected to trade between $0.7453 and $1.94, averaging $1.16 — a potential gain of +98% from today's $0.5855. That is up +15% on the projected 2028 average. Momentum favours further upside here.
Outlook Therapeutics, Inc.'s 2030 outlook centres on $1.11, within a $0.6802 to $1.93 range. That is -4% versus the projected 2029 average. That marks a +89% change versus current levels. Buyers look set to stay in control over this stretch.
By 2031, OTLK could reach as high as $1.80, with a base case around $0.9965 and support toward $0.5864 — roughly +70% from $0.5855. Momentum favours further upside here.
Expect OTLK to range from $0.7316 to $2.41 through 2032. The $1.30 average target implies a +121% move from current prices. That is up +30% on the projected 2031 average. Buyers look set to stay in control over this stretch.
The OTLK price prediction for 2033 points to an average of $1.46 (low $0.7886, high $2.78) — a potential gain of +149% on today's $0.5855. Momentum favours further upside here.
In 2034, OTLK is projected to trade between $0.9378 and $3.52, averaging $1.80 — a potential gain of +207% from today's $0.5855. That is up +24% on the projected 2033 average. Buyers look set to stay in control over this stretch.
Outlook Therapeutics, Inc.'s 2035 outlook centres on $2.24, within a $1.12 to $4.49 range. That is up +25% on the projected 2034 average. That marks a +283% change versus current levels. Momentum favours further upside here.
By 2040, OTLK could reach as high as $5.96, with a base case around $2.71 and support toward $1.22 — roughly +363% from $0.5855. Buyers look set to stay in control over this stretch.
Expect OTLK to range from $2.65 to $13.56 through 2050. The $5.90 average target implies a +907% move from current prices. That is up +118% on the projected 2040 average. Momentum favours further upside here.
Investing $1,000 in OTLK today (≈ 1,707.94193 OTLK) could be worth
$10,071.55
+$9,071.55 (+907%) by 2050 · US Dollar
Based on the average projected OTLK price of $5.9 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OTLKwould be worth at today's price.
$1,000 invested in OTLK on May 27, 2025 (≈ 621.118007 OTLK) would be worth
$363.66
-$636.34 (-63.6%) today · 0.36× · US Dollar
Based on a OTLK entry price of $1.61 vs. today's $0.5855.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.273 | $2,144.69 | +114.5% |
| 1 month ago | $0.285 | $2,054.39 | +105.4% |
| 3 months ago | $0.433 | $1,352.19 | +35.2% |
| 6 months ago | $1.79 | $327.09 | -67.3% |
| 1 year ago | $1.61 | $363.66 | -63.6% |
| All time (5.0y) ago | $55.2 | $10.61 | -98.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OTLK forecast.
Our base-case forecast reaches $1.20 around 2032.
Implied market cap at $1.20: $145.04M
The multi-year forecast depicts a bullish shift after 2026, with the average price rising from $0.5855 in 2026 to about $1.11 by 2030 and to $5.90 by 2050. The forecast includes rising max prices, such as $13.56 by 2050, and escalating ROIs (e.g., 66.2% in 2027, 89% in 2030, 362.6% in 2040, and 907.2% in 2050). While these are estimates and not guarantees, the trajectory shows meaningful upside as the years progress and sentiment remains bullish.
2026 carries a neutral stance with an average price equal to the current price, followed by a sustained bullish outlook through 2035 and beyond.
Tap a question to reveal the answer.
2030 avg $1.11 with a max of $1.93 and ROI of 89%, sentiment BULLISH.
The forecast shows bullish sentiment from 2027 onward with rising averages, including 2027 avg $0.9731, 2030 avg $1.11, 2040 avg $2.71, and 2050 avg $5.90. ROI progresses from 66.2% in 2027 to 907.2% in 2050, though 2026 is neutral and the current price is $0.5855.
The 2040 forecast shows a max of $5.96, with an average of $2.71, indicating the possibility of exceeding $5 in that horizon, though it remains an estimate.
Current price is $0.5855 per share and market capitalization is $70.77M.
The 30-day range is between $0.2931 and $1.17.
Outlook Therapeutics, Inc. Community Discussion
0Share your Outlook Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.